QL47

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer Lymphatic System Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	5 mg
Quantity options	10mM*1 mL 10 mg 50 mg 5 mg
Item no.	HY-80003-5mg
Targets	BTK
CASRN	1469988-75-7
eClass 6.1	30220300
eClass 9.0	32160605
Available
Alias	1469988-75-7
Purity	98.11
Product Description	QL47, a broad-spectrum antiviral agent, inhibits dengue virus and other RNA viruses. QL47 selectively inhibits eukaryotic translation. QL47 is a potent covalent inhibitor of BTK with an IC50 of 7 nM[1][2][3].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	447.49
Clinical_Information	No Development Reported
Manufacturers Research Area	Cancer; Infection
Manufacturers Target	Btk; Dengue virus; Flavivirus
Pathway	Anti-infection; Protein Tyrosine Kinase/RTK

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-80003-5mg-safety-datasheet.pdf